Adenocarcinoma of the uterine cervix in Ireland and Sweden: Human papillomavirus infection and biologic alterations

Modern Pathology

Volumn 12, Issue 7, 1999, Pages 675-682

  Skyldberg, Barbro M ^a,b   Murray, Eimear ^c   Lambkin, Helen ^c   Kelehan, Peter ^d   Auer, Gert U ^a  

^a Cancer Center Karolinska   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^d NATIONAL MATERNITY HOSPITAL   (Ireland)

Author keywords

Cervical adenocarcinoma; Cyclin A; DNA cytometry; Human papillomavirus; Ki 67; p21 WAF1; p53

Indexed keywords

CYCLIN A; KI 67 ANTIGEN; PROTEIN P21; PROTEIN P53; VIRUS DNA;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IRELAND; PLOIDY; PRIORITY JOURNAL; SWEDEN; TETRAPLOIDY; UTERINE CERVIX CARCINOMA; VIRUS INFECTION; WART VIRUS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CELL DIVISION; CERVIX UTERI; CYCLIN A; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA, NEOPLASM; DNA, VIRAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IRELAND; KI-67 ANTIGEN; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYPLOIDY; SWEDEN; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0032819118     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Parazzini F, La Vecchia C. Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 1990;39:40-6.
2. Stockton D, Cooper P, Lonsdale RN. Changing incidence of invasive adenocarcinoma of the uterine cervix in East Anglia. J Med Screen 1997;4:40-3.
3. Vizcaino AP, Moreno V, Bosch FX, Muñoz N, Barros-Dios XM, Parkin DM. International trends in the incidence of cervical cancer. I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer 1998;75:536-45.
4. zur Hausen H. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 1991;184:9-13.
5. Tase T, Okagaki T, Clark BA, Manias DA, Ostrow RS, Twiggs EB, et al. Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization. Cancer Res 1988;48:993-8.
6. Wilczynski SP, Walker J, Liao S-Y, Bergen S, Berman M. Adenocarcinoma of the cervix associated with human papillomavirus. Cancer 1988;62:1331-6.
7. Bjersing L, Rogo K, Evander M, Gerdes U, Stendahl U, Wadell G. HPV 18 and cervical adenocarcinomas. Anticancer Res 1991;11:123-7.
8. Johnson TE, Kim W, Plieth DA, Sarkar FH. Detection of HPV-16/18 DNA in cervical adenocarcinoma using polymerase chain reaction (PCR) methodology. Mod Pathol 1992;5: 35-40.
9. Cooper K, Herrington CS, Lo ES, Evans MF, McGee JO. Integration of human papillomavirus types 16 and 18 in cervical adenocarcinoma. J Clin Pathol 1992;45:382-4.
10. Hording U, Teglbjaerg CS, Visfeldt J, Bock J. Human papillomavirus types 16 and 18 in adenocarcinoma of the uterine cervix. Gynecol Oncol 1992;46:313-6.
11. Milde-Langosch K, Schreiber C, Becker G, Löning T, Stegner HE. Human papillomavirus detection in cervical adenocarcinoma by polymerase chain reaction. Hum Pathol 1993;24: 590-4.
12. Lee KR, Howard P, Heintz NH, Collins CC. Low prevalence of human papillomavirus types 16 and 18 in cervical adenocarcinoma in situ, invasive adenocarcinoma, and glandular dysplasia by polymerase chain reaction. Mod Pathol 1993;6: 433-7.
13. Yamakawa Y, Forslund O, Teshima H, Hasumi K, Kitagawa T, Hansson BG. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Gynecol Oncol 1994;53:190-5.
14. Duggan MA, McGregor E, Benoit JE, Inoue M, Nation JG, Stuart GCE. The human papillomavirus status of invasive cervical adenocarcinoma: a clinicopathological and outcome analysis. Hum Pathol 1995;26:319-25.
15. Iwasawa A, Nieminen P, Lehtinen M, Paavonen J. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer 1996;77:2275-9.
16. Tenti P, Romagnoli S, Silini E, Zappatore R, Spinillo A, Giunta P, et al. Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix: PCR analysis of 138 cases and correlation with histologic type and grade. Am J Clin Pathol 1996;106:52-6.
17. Parker MF, Arroyo GF, Geradts J, Sabichi AL, Park RC, Taylor RR, et al. Molecular characterization of adenocarcinoma of the cervix. Gynecol Oncol 1997;64:242-51.
18. Ferguson AW, Svoboda-Newman SM, Frank TS. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol 1998;11:11-8.
19. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991;253:49-53.
20. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 1990;248:76-9.
21. Crook T, Wrede D, Tidy JA, Mason WP, Evans DJ, Vousden KH. Clonal p53 mutation in primary cervical cancer: association with human papillomavirus-negative tumours. Lancet 1992;339:1070-3.
22. Tsuda H, Hirohashi S. Frequent occurrence of p53 gene mutations in uterine cancers at advanced clinical stage and with aggressive histological phenotypes. Jpn J Cancer Res 1992;83:1184-91.
23. Börresen AL, Helland A, Nesland J, Holm R, Trope C, Kaern J. Papillomaviruses, p53, and cervical cancer. Lancet 1992; 339:1350-1.
24. Busby-Earle RM, Steel CM, Williams AR, Cohen B, Bird CC. p53 mutations in cervical carcinogenesis: low frequency and lack of correlation with human papillomavirus status. Br J Cancer 1994;69:732-7.
25. Wrede D, Tidy JA, Crook T, Lane D, Vousden KH. Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Mol Carcinog 1991;4:171-5.
26. Crook T, Wrede D, Vousden KH. p53 point mutation in HPV-negative human cervical carcinoma cell lines. Oncogene 1991;6:873-5.
27. Tsuda H, Jiko K, Tsugane S, Yajima M, Yamada T, Tanemura K, et al. Prognostic value of p53 protein accumulation in cancer cell nuclei in adenocarcinoma of the uterine cervix. Jpn J Cancer Res 1995;86:11049-53.
28. Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Gynecol Oncol 1997;65:23-9.
29. waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix. Mod Pathol 1997;10:578-84.
30. Naslund I, Rubico CA, Auer GU. Nuclear DNA changes during pathogenesis of squamous carcinoma of the cervix in 3,4-benzopyrene-treated mice. Anal Quant Cytol Histol 1987;9:411-8.
31. de Roda Husman AM, Walboomers JM, van den Brule AJ, Meijer CJ, Snijders PJ. The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 1995;76:1057-62.
32. Skyldberg B, Kalantari M, Kärki M, Johansson B, Hagmar B, Walaas L. Detection of HPV infection in tissue blocks by in situ hybridization as compared to a PCR procedure. Hum Pathol 1991;22:578-82.
33. Ehrlich HA, Bugawan TL. HLA class II gene polymorphism: DNA typing, evolution, and relationship to disease susceptibility. In: Ehrlich HA, editor. PCR technology: principles and applications for DNA amplification. New York: Stockton Press; 1989. p. 193-208.
34. Auer GU, Heselmeyer KM, Steinbeck RG, Munck-Wikland E, Zetterberg AD. The relationship between aneuploidy and p53 overexpression during genesis of colorectal adenocarcinoma. Virchows Arch 1994;424:343-7.
35. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, et al. A p53-dependent mouse spindle check-point. Science 1995;267:1353-6.
36. Tenti P, Pavanello S, Padovan L, Spinillo A, Vesentini N, Zappatore R, et al. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix. Am J Pathol 1998;152:1057-63.
37. Cina SJ, Richardson MS, Austin RM, Kurman RJ. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix. Mod Pathol 1997;10:176-80.
38. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54: 4855-78.
39. Jiko K, Tsuda H, Sato S, Hirohashi S. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus. Int J Cancer 1994;59:601-6.
40. Milde-Langosh K, Albrecht K, Joram S, Schlechte H, Giesing M, Löning T. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer 1995;63:639-45.